Daxor Corporation (DXR) Dividend History

Daxor Corporation (DXR) is a medical device company specializing in blood volume measurement technology. It is known for its BVA-100 Blood Volume Analyzer, which provides precise blood volume readings to aid in the diagnosis and management of various health conditions, including anemia, heart failure, and blood disorders. The company has a long-standing history of developing and commercializing innovative diagnostic tools within the healthcare industry.

350 Fifth Avenue, New York, NY, 10118
Phone: (212) 244-0555
Website: https://www.daxor.com
Dividend Yield: 0.29%
Dividend Frequency: Annually

Dividend History

Pay Date Amount Ex Dividend Date Record Date
January 12, 2018 $0.03 01/05/2018 01/08/2018
December 29, 2016 $0.03 12/20/2016 12/22/2016
December 29, 2015 $0.04 12/18/2015 12/22/2015
December 26, 2014 $0.03 12/04/2014 12/08/2014
December 27, 2013 $0.05 12/05/2013 12/09/2013
Show more

Dividends Summary

  • Daxor Corporation has issued 18 dividend payments over the past 10 years
  • The most recent dividend was paid 2776 days ago, on January 12, 2018
  • The first recorded dividend was paid on August 27, 2008
  • The highest dividend payout was $1.00 per share
  • The average dividend over this 10 year span is $0.25 per share
  • Daxor Corporation has decreased its dividend payments by 88.00% since 2008

Company News

  • Daxor Corporation, a leader in blood volume measurement technology, will showcase its innovative Blood Volume Analysis (BVA) at the MedAxiom Cardiovascular Transforum Spring 2025 conference. WellStar Health System will present findings on how BVA-driven strategies significantly reduced kidney injury following LVAD implantation.

    GlobeNewswire Inc.
  • Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. AVROBIO, Inc. (NASDAQ: AVRO) gained 93.5% to $1.50 after the company announced it would sell its gene therapy program to Novartis for $87.5 million. Microbot Medical Inc. (NASDAQ: MBOT) rose 66% to $2.0450 after the company announced it achieved a 100% success rate for the LIBERTY system in an extensive pre-clinical animal study performed by leading European physicians. Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) shares gained 39.7% to $12.45 after the company announced results of its phase 2 study to treat liver function. VectivBio Holding AG (NASDAQ: VECT) climbed 38.5% to $16.20 after Ironwood Pharmaceuticals announced it would acquire the company for $17 per share. Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) shares climbed 33.5% to $4.9375. Tang Capital Partners, Concentra sent acquisition proposal to Atea Pharmaceuticals with terms to acquire all of its outstanding common stock. Appreciate Holdings, Inc. (NASDAQ: SFR) gained 30% to $0.3551. Appreciate announced receipt of notice from Nasdaq regarding late filing of its form 10-Q and 10-K. D-Wave Quantum Inc. (NYSE: QBTS) surged 25.5% to $0.6080. Benchmark reiterated D-Wave Quantum with a Buy and maintained a $2 price target. CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) shares climbed 24.3% to $1.9850 after gaining around 18% on Friday. CNS Pharmaceuticals posted a wider first-quarter loss. SeqLL Inc. (NASDAQ: SQL) shares climbed 23.9% to $0.4149 after dropping 14% on Friday. SeqLL recently posted a wider first-quarter loss. Cricut, Inc. (NASDAQ: CRCT) gained 22.2% to $8.78. Cricut declared a $234 million special cash dividend of $1/share to holders of the company’s Class A and Class B common stock. Yunji Inc. (NASDAQ: YJ) gained 19.8% to $0.22. Histogen Inc. (NASDAQ: HSTO) rose 18.7% to $1.00. Absci Corporation (NASDAQ: ABSI) jumped 18.7% to $1.65. ADS-TEC Energy PLC (NASDAQ: ADSE) rose 18.6% to $7.13. Akebia Therapeutics, Inc. (NASDAQ:

    Benzinga
Page data last updated 08/19/2025 16:50:15 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included